NERVMinerva Neurosciences, Inc.

2.30+2.73%· post 2.30

Mkt cap$110.8MRevenue—Revenue—

LGVNLongeveron Inc.

1.78+1.71%· post 1.78

ClosedOct 30 '26

Mkt cap$5.2MRevenue$287,000Q2 FY26Revenue$1MFY25

Compare

ClosedOct 30 '26

NERVMinerva Neurosciences, Inc.

LGVNLongeveron Inc.

2.30+2.73%post 2.30

Price

1.78+1.71%post 1.78

$110.8M

Mkt cap

$5.2M

—

Revenue

$287,000Q2 FY26

—

Revenue

$1MFY25

NERVMinerva Neurosciences, Inc.

Mkt capRevenueRevenue

LGVNLongeveron Inc.

Mkt capRevenueRevenue

Compare

NERVMinerva Neurosciences, Inc.

LGVNLongeveron Inc.

Price

Mkt cap

Revenue

Earnings history

last 4 reports each · paired by recencyMethod

NERV1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±82.1%−3.83%×0.05

LGVN1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—−6.60%—

= impliedNERV realized, solidLGVN realized, hatchedOne scale, both sides: full bar = 83%× = |realized| ÷ impliedSource: market data

NERV compared with LGVN: revenue, margins and what each company keeps, and the suppliers and customers both name